Cerus Corporation Company Profile (NASDAQ:CERS)

About Cerus Corporation

Cerus Corporation logoCerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company's INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The Company's INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, including human immunodeficiency virus (HIV), West Nile, Severe acute respiratory syndrome (SARS), hepatitis B and C; bacteria and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products. The Company's INTERCEPT Blood System is for use with blood components, including plasma, platelets, and red blood cells.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: CERS
  • CUSIP: 15708510
Key Metrics:
  • Previous Close: $4.28
  • 50 Day Moving Average: $4.20
  • 200 Day Moving Average: $5.29
  • 52-Week Range: $103,466,000.00 - $3.97
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.12
  • P/E Growth: 0.00
  • Market Cap: $441.80M
  • Outstanding Shares: 103,466,000
  • Beta: 2.06
Profitability:
  • Net Margins: -174.76%
  • Return on Equity: -76.76%
  • Return on Assets: -49.53%
Debt:
  • Debt-to-Equity Ratio: 0.20%
  • Current Ratio: 4.72%
  • Quick Ratio: 4.19%
Additional Links:
Companies Related to Cerus Corporation:

Analyst Ratings

Consensus Ratings for Cerus Corporation (NASDAQ:CERS) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $9.25 (116.63% upside)

Analysts' Ratings History for Cerus Corporation (NASDAQ:CERS)
Show:
DateFirmActionRatingPrice TargetDetails
2/23/2017BTIG ResearchReiterated RatingBuy$8.00View Rating Details
12/22/2016FBR & CoReiterated RatingOutperform$10.00View Rating Details
11/6/2016Cantor FitzgeraldSet Price TargetBuy$9.00View Rating Details
8/6/2016Robert W. BairdSet Price TargetBuy$9.00 -> $10.00View Rating Details
2/6/2016StephensReiterated RatingBuyView Rating Details
1/29/2016Cowen and CompanyReiterated RatingBuyView Rating Details
12/17/2015WedbushDowngradeOutperform -> Neutral$6.50View Rating Details
6/30/2015MLV & Co.Reiterated RatingBuy$10.00View Rating Details
(Data available from 2/26/2015 forward)

Earnings

Earnings History for Cerus Corporation (NASDAQ:CERS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2017        
11/3/2016Q316($0.17)($0.14)$10.34 million$10.20 millionViewN/AView Earnings Details
8/4/2016Q216($0.17)($0.18)$8.88 million$9.25 millionViewN/AView Earnings Details
5/3/2016Q1($0.16)($0.17)$8.29 million$7.60 millionViewN/AView Earnings Details
3/8/2016Q415($0.16)($0.15)$9.72 million$9.70 millionViewListenView Earnings Details
11/5/2015Q315($0.16)($0.17)$10.00 million$8.04 millionViewN/AView Earnings Details
8/6/2015Q215($0.15)($0.17)$8.71 million$8.83 millionViewN/AView Earnings Details
5/5/2015Q214($0.16)($0.17)$7.70 million$7.70 millionViewN/AView Earnings Details
2/26/2015Q114($0.15)($0.25)$10.36 million$9.70 millionViewN/AView Earnings Details
11/4/2014Q413($0.13)($0.15)$9.83 million$10.36 millionViewN/AView Earnings Details
7/31/2014Q313($0.13)($0.16)$8.17 million$8.60 millionViewN/AView Earnings Details
5/1/2014Q313($0.12)($0.12)$9.65 million$7.86 millionViewN/AView Earnings Details
2/25/2014Q213($0.09)($0.10)$11.77 million$9.23 millionViewN/AView Earnings Details
10/29/2013($0.09)($0.29)$10.34 million$10.54 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cerus Corporation (NASDAQ:CERS)
Current Year EPS Consensus Estimate: $-0.64 EPS
Next Year EPS Consensus Estimate: $-0.60 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.17)($0.17)($0.17)
Q2 20161($0.16)($0.16)($0.16)
Q3 20161($0.16)($0.16)($0.16)
Q4 20161($0.16)($0.16)($0.16)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cerus Corporation (NASDAQ:CERS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cerus Corporation (NASDAQ:CERS)
Insider Ownership Percentage: 6.60%
Institutional Ownership Percentage: 68.91%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/22/2016Kevin Dennis GreenCFOSell17,150$6.80$116,620.00View SEC Filing  
8/19/2015Laurence M CorashInsiderBuy25,900$4.99$129,241.00View SEC Filing  
8/18/2015Laurence M CorashInsiderBuy84,600$4.77$403,542.00View SEC Filing  
11/10/2014William Mariner GreenmanCEOBuy21,800$3.93$85,674.00View SEC Filing  
11/19/2012William Mariner GreenmanCEOBuy3,200$3.02$9,664.00View SEC Filing  
11/16/2012Laurence M CorashInsiderBuy2,000$2.85$5,700.00View SEC Filing  
11/16/2012William Mariner GreenmanCEOBuy13,800$2.85$39,330.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cerus Corporation (NASDAQ:CERS)
DateHeadline
News IconTrading Circle: Narrowing in on Shares of Cerus Corporation (NASDAQ:CERS) - Midway Monitor (NASDAQ:CERS)
midwaymonitor.com - February 24 at 4:24 PM
News IconHot Stocks Report: Actinium Pharmaceuticals, Inc. (ATNM), Cerus Corporation (CERS) - Post Analyst (NASDAQ:CERS)
postanalyst.com - February 24 at 4:24 PM
marketexclusive.com logoAnalyst Activity – BTIG Research Reiterates Buy on Cerus ... - Market Exclusive (NASDAQ:CERS)
marketexclusive.com - February 24 at 4:24 PM
marketexclusive.com logoAnalyst Activity – BTIG Research Reiterates Buy on Cerus Corporation (NASDAQ:CERS) (NASDAQ:CERS)
marketexclusive.com - February 23 at 4:12 PM
tmcnet.com logoCerus to Release Fourth Quarter and Year End … (NASDAQ:CERS)
www.tmcnet.com - February 22 at 4:22 PM
News IconFirst Week of April 21st Options Trading For Cerus Corp. (NASDAQ:CERS)
www.stockoptionschannel.com - February 22 at 4:22 PM
News IconAnalyst's Proposition on TherapeuticsMD, Inc. (TXMD), Cerus Corporation (CERS) - The USA Commerce (NASDAQ:CERS)
www.theusacommerce.com - February 21 at 2:40 PM
finance.yahoo.com logoCerus to Release Fourth Quarter and Year End 2016 Results on March 7, 2017 (NASDAQ:CERS)
finance.yahoo.com - February 21 at 2:40 PM
News IconCerus Corporation (CERS): How technical signals have emerged? - Post Analyst (NASDAQ:CERS)
postanalyst.com - February 20 at 11:53 AM
investornewswire.com logoSentiments And Ratings Alert: Cerus Corporation (NASDAQ:CERS) - Investor Newswire (NASDAQ:CERS)
www.investornewswire.com - February 19 at 11:25 AM
News IconCerus Corporation (CERS) added to 23 new portfolios | Post Analyst - Post Analyst (NASDAQ:CERS)
postanalyst.com - February 19 at 11:25 AM
News IconTechnical Tracker: Watching Shares of Cerus Corporation (CERS) - BVN (NASDAQ:CERS)
bvnewsjournal.com - February 16 at 4:21 PM
News IconChart Watch: Following Indicators on Shares of Cerus Corporation (CERS) - The Standard (NASDAQ:CERS)
6milestandard.com - February 16 at 9:20 AM
News IconInvestor Focus on Shares of Cerus Corporation (NASDAQ:CERS) - Benton Bulletin (NASDAQ:CERS)
bentonbulletin.com - February 11 at 2:33 AM
4-traders.com logoCerus : Research Reports Initiation on Biotech Stocks -- Portola Pharma, Tesaro, Sangamo Therapeutics, and Cerus (NASDAQ:CERS)
www.4-traders.com - January 31 at 4:40 PM
News IconTechnical Roundup on Shares of Cerus Corporation (CERS) - Rives Journal (NASDAQ:CERS)
rivesjournal.com - January 29 at 4:15 PM
News IconStock Spotlight: Zooming in on Shares of Cerus Corporation (NASDAQ:CERS) - The Tribune (NASDAQ:CERS)
lakecitytribune.com - January 26 at 3:22 AM
News IconTrading Sheet: Tracking Technicals for Cerus Corporation (CERS) - Sherwood Daily (NASDAQ:CERS)
sherwooddaily.com - January 24 at 4:48 PM
News IconLooking Ahead for Cerus Corporation (NASDAQ:CERS); Are These Shares Ready to Go Higher? - Aiken Advocate (NASDAQ:CERS)
aikenadvocate.com - January 24 at 4:48 PM
News IconEarnings in Full Force, Analysts Take Aim at Cerus Corporation (NASDAQ:CERS) - Wall Street Beacon (NASDAQ:CERS)
wsbeacon.com - January 24 at 4:48 PM
News IconChecking on CCI, MA, RSI and ADX for Cerus Corporation (CERS) - Sherwood Daily (NASDAQ:CERS)
sherwooddaily.com - January 22 at 4:15 PM
News IconWall Street Holds Inauguration Gains, How Did This Stock Fare: Cerus Corporation (NASDAQ:CERS) - Wall Street Beacon (NASDAQ:CERS)
wsbeacon.com - January 22 at 4:15 PM
News IconTrading Insight: Taking a Look at Levels for Cerus Corporation (CERS) - Rives Journal (NASDAQ:CERS)
rivesjournal.com - January 21 at 4:16 PM
finance.yahoo.com logoBaron Funds Comments on Cerus Corp (NASDAQ:CERS)
finance.yahoo.com - January 20 at 5:24 PM
News IconDragged Through The Mud, Stock Hits New Low: Cerus Corporation (NASDAQ:CERS) - Wall Street Beacon (NASDAQ:CERS)
wsbeacon.com - January 20 at 3:29 AM
News IconWill The Needle Move For Cerus Corporation (NASDAQ:CERS) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:CERS)
wsbeacon.com - January 18 at 3:39 PM
News IconStock Mover of the Day: Cerus Corporation's Stock Is Sell After ... - Fair View Times (NASDAQ:CERS)
fairviewtimes.com - January 18 at 3:39 PM
News IconStock Getting Tripped Up In Session: Cerus Corporation (NASDAQ:CERS) - Wall Street Beacon (NASDAQ:CERS)
wsbeacon.com - January 11 at 9:38 PM
News IconGrowth Story Unfolding for Cerus Corporation (NASDAQ:CERS) - Prospect Journal (NASDAQ:CERS)
prospectjournal.com - January 9 at 10:23 PM
News IconCerus Corp CERS Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NASDAQ:CERS)
www.bioportfolio.com - January 7 at 4:46 PM
publicnow.com logoCerus Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) (NASDAQ:CERS)
www.publicnow.com - January 4 at 5:17 PM
News IconAre There Catalysts to Propel This Stock Forward: Cerus Corporation (NASDAQ:CERS) - Prospect Journal (NASDAQ:CERS)
prospectjournal.com - December 26 at 4:02 PM
marketexclusive.com logoAnalyst Activity – FBR & Co Reiterates Outperform on Cerus Corp. (NASDAQ:CERS) (NASDAQ:CERS)
marketexclusive.com - December 22 at 4:22 PM
capitalcube.com logoETFs with exposure to Cerus Corp. : December 22, 2016 (NASDAQ:CERS)
www.capitalcube.com - December 22 at 4:22 PM
stocksdaily.net logoCan Cerus Corporation (NASDAQ:CERS) Post EPS Of $-0.15? - Stocks Daily (NASDAQ:CERS)
www.stocksdaily.net - December 22 at 2:25 AM
News IconCerus raises funds for phase III trial of Intercept red blood cell system (NASDAQ:CERS)
www.massdevice.com - December 21 at 2:53 AM
News IconMarket Scope: Taking a Look at Cerus Corporation (NASDAQ:CERS) - Liberty News (NASDAQ:CERS)
libertynewsrecord.com - December 20 at 9:52 PM
News IconAverage Directional Index Review for Cerus Corporation (CERS) - Yankee Analysts (NASDAQ:CERS)
yankeeanalysts.com - December 20 at 4:50 PM
News IconStock Concentration on Shares of Cerus Corporation (NASDAQ:CERS) - OIB News (NASDAQ:CERS)
oibnews.com - December 20 at 7:32 AM
News IconUpdate on Valuation Formula's For Cerus Corporation (NASDAQ:CERS) - Marion Business Daily (NASDAQ:CERS)
marionbusinessdaily.com - December 20 at 7:32 AM
finance.yahoo.com logo8:31 am Cerus extends the target timing for CE Mark submission of the INTERCEPT Blood System for Red Blood Cells in Europe and announces that additional options totaling $10,825,555 have been exercised under its contract with the BARDA (NASDAQ:CERS)
finance.yahoo.com - December 20 at 7:32 AM
publicnow.com logoCerus Provides an Update on the Timeline for the INTERCEPT Blood System for Red Blood Cells in Europe (NASDAQ:CERS)
www.publicnow.com - December 20 at 7:32 AM
publicnow.com logoCerus Announces Exercise of Additional BARDA Contract Options Totaling $10,825,555 for Activities Related to Its Planned Phase III Trial of the INTERCEPT Red Blood Cell System (NASDAQ:CERS)
www.publicnow.com - December 20 at 7:32 AM
seekingalpha.com logoBARDA stays the course with Cerus' INTERCEPT, exercises $10.8M in development options (NASDAQ:CERS)
seekingalpha.com - December 19 at 11:53 AM
News IconVC Score In Focus for Cerus Corporation (NASDAQ:CERS) - The Business Journal (NASDAQ:CERS)
belmontbusinessjournal.com - December 17 at 9:24 PM
News IconEquity in Focus: Cerus Corporation (NASDAQ:CERS) - Business Daily Leader (NASDAQ:CERS)
businessdailyleader.com - December 17 at 9:24 PM
News IconCompany Stock in Focus: Cerus Corporation (NASDAQ:CERS) - Liberty News (NASDAQ:CERS)
libertynewsrecord.com - December 16 at 4:37 PM
News IconMarket Center: Watching the Levels for Cerus Corporation (NASDAQ:CERS) - OIB News (NASDAQ:CERS)
oibnews.com - December 15 at 9:40 PM
News IconCompany Review: Narrowing in on Shares of Cerus Corporation (NASDAQ:CERS) - Liberty News (NASDAQ:CERS)
libertynewsrecord.com - December 14 at 5:12 PM
News IconWhat The Charts Are Saying About Cerus Corporation (NASDAQ:CERS) - Marion Business Daily (NASDAQ:CERS)
marionbusinessdaily.com - December 14 at 5:12 PM

Social

What is Cerus Corporation's stock symbol?

Cerus Corporation trades on the NASDAQ under the ticker symbol "CERS."

Where is Cerus Corporation's stock going? Where will Cerus Corporation's stock price be in 2017?

4 brokers have issued 1-year price objectives for Cerus Corporation's shares. Their forecasts range from $8.00 to $10.00. On average, they anticipate Cerus Corporation's share price to reach $9.25 in the next year.

When will Cerus Corporation announce their earnings?

Cerus Corporation is scheduled to release their next quarterly earnings announcement on Monday, March, 6th 2017.

Who owns Cerus Corporation stock?

Cerus Corporation's stock is owned by a number of of institutional and retail investors. Top institutional investors include State Street Corp (1.73%), ARK Investment Management LLC (0.64%), Royce & Associates LP (0.24%), Baird Financial Group Inc. (0.20%), Trexquant Investment LP (0.10%) and A.R.T. Advisors LLC (0.09%). Company insiders that own Cerus Corporation stock include Kevin Dennis Green and Laurence M Corash.

Who sold Cerus Corporation stock? Who is selling Cerus Corporation stock?

Cerus Corporation's stock was sold by a variety of institutional investors in the last quarter, including Metropolitan Life Insurance Co. NY.

Who bought Cerus Corporation stock? Who is buying Cerus Corporation stock?

Cerus Corporation's stock was acquired by a variety of institutional investors in the last quarter, including ARK Investment Management LLC, Trexquant Investment LP, A.R.T. Advisors LLC, Renaissance Technologies LLC, J. Goldman & Co LP, Bayesian Capital Management LP, State Street Corp and Baird Financial Group Inc..

How do I buy Cerus Corporation stock?

Shares of Cerus Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Cerus Corporation stock cost?

One share of Cerus Corporation stock can currently be purchased for approximately $4.27.

Cerus Corporation (NASDAQ:CERS) Chart for Sunday, February, 26, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Cerus Corporation (NASDAQ:CERS)

Earnings History Chart

Earnings by Quarter for Cerus Corporation (NASDAQ:CERS)

Dividend History Chart

Dividend Payments by Quarter for Cerus Corporation (NASDAQ:CERS)

Last Updated on 2/26/2017 by MarketBeat.com Staff